Key result
Treatment of biopsy-negative rejection with immunosuppressive therapy resulted in a return to normal left ventricular function in 58.3% of cases within a mean of 14 days.
Why the study?
Does immunosuppressive therapy improve left ventricular function in heart transplant patients with biopsy-negative rejection?
Observational (n=11)
Does immunosuppressive therapy improve left ventricular function in heart transplant patients with biopsy-negative rejection?
Biopsy-negative rejection with cardiac dysfunction in heart transplant patients can often be reversed with appropriate immunosuppressive therapy.
Answers are grounded in this paper and cite their sources.
May support empiric immunosuppression for biopsy-negative rejection with LV dysfunction; hypothesis-generating and requires prospective validation.
Purpose. The most recent International Society for Heart and Lung Transplantation (ISHLT) biopsy scale classifies cellular and antibody-mediated rejections. However, there are cases with acute decline in left ventricular ejection fraction (LVEF ≤ 45%) but no evidence of rejection on biopsy. Characteristics and treatment response of this biopsy negative rejection (BNR) have yet to be elucidated. Methods. Between 2002 and 2012, we found 12 cases of BNR in 11 heart transplant patients as previously defined. One of the 11 patients was treated a second time for BNR. Characteristics and response to treatment were noted. Results. 12 cases (of 11 patients) were reviewed and 11 occurred during the first year after transplant. 8 cases without heart failure symptoms were treated with an oral corticosteroids bolus and taper or intravenous immunoglobulin. Four cases with heart failure symptoms were treated with thymoglobulin, intravenous immunoglobulin, and intravenous methylprednisolone followed by an oral corticosteroids bolus and taper. Overall, 7 cases resulted in return to normal left ventricular function within a mean of 14 ± 10 days from the initial biopsy. Conclusion. BNR includes cardiac dysfunction and can be a severe form of rejection. Characteristics of these cases of rejection are described with most cases responding to appropriate therapy.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2013) conducted an observational in Biopsy-negative rejection after heart transplantation (n=11). Immunosuppressive therapy (corticosteroids, IVIG, thymoglobulin) was evaluated on Return to normal left ventricular function. Treatment of biopsy-negative rejection with immunosuppressive therapy resulted in a return to normal left ventricular function in 58.3% of cases within a mean of 14 days.
Synapse has enriched 10 related papers. Consider them for comparative context: